Patient Blood Management - from local initiatives to European collaborations

Publikation: Bidrag til tidsskriftKonferenceartikelForskningpeer review

Resumé

Patient blood management (PBM), as defined by the WHO, is a patient‐focused, evidence‐based and systematic approach to optimize the management of patient and transfusion of blood products for quality and effective patient care. It is designed to improve patient outcomes through the safe and rational use of blood and blood products and by minimizing unnecessary exposure to blood products. Important elements of PBM are optimizing haemoglobin concentrations without blood transfusion, minimizing blood loss and managing anaemia, especially by use of evidence‐based transfusion guidelines and pharmacological agents. Local PBM initiatives differ substantially. In one region of Denmark, the majority of PBM initiatives over the last 10 years have been based on provider education and enforcement of national guidelines. Evaluation of the effect of these initiatives indicated that education alone can be an effective and durable method of reducing unnecessary transfusions. To improve implementation and knowledge of PBM, benchmarking of experiences between hospitals and countries seems rational, and several initiatives regarding PBM are being undertaken in Europe. Patient Blood Management in Europe (PaBloE) is a working group of the European Blood Alliance. Its objectives are to derive good practices in PBM and to develop ways to implement these practices. Within this group, several surveys have been performed relating to blood product consumption, implementation of PBM, and knowledge of PBM principles and practices among clinicians. These surveys have shown variation in transfusion rates between the participating hospitals, and variable implementation of PBM activities and monitoring of transfusion practice.
OriginalsprogEngelsk
BogserieI S B T Science Series
Vol/bind12
Udgave nummer4 (Special Issue)
Sider (fra-til)435-440
ISSN1751-2816
DOI
StatusUdgivet - 2017
Begivenhed27th Regional Congress of the International Society of Blood Transfusion - København, Danmark
Varighed: 17. jun. 201721. jun. 2017
Konferencens nummer: 27

Konference

Konference27th Regional Congress of the International Society of Blood Transfusion
Nummer27
LandDanmark
ByKøbenhavn
Periode17/06/201721/06/2017

Fingeraftryk

Guidelines
Knowledge Management
Education
Benchmarking
Practice Management
Denmark
Surveys and Questionnaires

Citer dette

@inproceedings{12375ef5ad0442b6b3275aefc31559b3,
title = "Patient Blood Management - from local initiatives to European collaborations",
abstract = "Patient blood management (PBM), as defined by the WHO, is a patient‐focused, evidence‐based and systematic approach to optimize the management of patient and transfusion of blood products for quality and effective patient care. It is designed to improve patient outcomes through the safe and rational use of blood and blood products and by minimizing unnecessary exposure to blood products. Important elements of PBM are optimizing haemoglobin concentrations without blood transfusion, minimizing blood loss and managing anaemia, especially by use of evidence‐based transfusion guidelines and pharmacological agents. Local PBM initiatives differ substantially. In one region of Denmark, the majority of PBM initiatives over the last 10 years have been based on provider education and enforcement of national guidelines. Evaluation of the effect of these initiatives indicated that education alone can be an effective and durable method of reducing unnecessary transfusions. To improve implementation and knowledge of PBM, benchmarking of experiences between hospitals and countries seems rational, and several initiatives regarding PBM are being undertaken in Europe. Patient Blood Management in Europe (PaBloE) is a working group of the European Blood Alliance. Its objectives are to derive good practices in PBM and to develop ways to implement these practices. Within this group, several surveys have been performed relating to blood product consumption, implementation of PBM, and knowledge of PBM principles and practices among clinicians. These surveys have shown variation in transfusion rates between the participating hospitals, and variable implementation of PBM activities and monitoring of transfusion practice.",
author = "Bruun, {Mie Topholm} and J{\o}rgen Georgsen and Kjell Titlestad and Mark Yazer and Murphy, {M F}",
year = "2017",
doi = "10.1111/voxs.12369",
language = "English",
volume = "12",
pages = "435--440",
journal = "I S B T Science Series",
issn = "1751-2816",
publisher = "Wiley-Blackwell",
number = "4 (Special Issue)",

}

Patient Blood Management - from local initiatives to European collaborations. / Bruun, Mie Topholm; Georgsen, Jørgen; Titlestad, Kjell; Yazer, Mark; Murphy, M F.

I: I S B T Science Series, Bind 12, Nr. 4 (Special Issue), 2017, s. 435-440.

Publikation: Bidrag til tidsskriftKonferenceartikelForskningpeer review

TY - GEN

T1 - Patient Blood Management - from local initiatives to European collaborations

AU - Bruun, Mie Topholm

AU - Georgsen, Jørgen

AU - Titlestad, Kjell

AU - Yazer, Mark

AU - Murphy, M F

PY - 2017

Y1 - 2017

N2 - Patient blood management (PBM), as defined by the WHO, is a patient‐focused, evidence‐based and systematic approach to optimize the management of patient and transfusion of blood products for quality and effective patient care. It is designed to improve patient outcomes through the safe and rational use of blood and blood products and by minimizing unnecessary exposure to blood products. Important elements of PBM are optimizing haemoglobin concentrations without blood transfusion, minimizing blood loss and managing anaemia, especially by use of evidence‐based transfusion guidelines and pharmacological agents. Local PBM initiatives differ substantially. In one region of Denmark, the majority of PBM initiatives over the last 10 years have been based on provider education and enforcement of national guidelines. Evaluation of the effect of these initiatives indicated that education alone can be an effective and durable method of reducing unnecessary transfusions. To improve implementation and knowledge of PBM, benchmarking of experiences between hospitals and countries seems rational, and several initiatives regarding PBM are being undertaken in Europe. Patient Blood Management in Europe (PaBloE) is a working group of the European Blood Alliance. Its objectives are to derive good practices in PBM and to develop ways to implement these practices. Within this group, several surveys have been performed relating to blood product consumption, implementation of PBM, and knowledge of PBM principles and practices among clinicians. These surveys have shown variation in transfusion rates between the participating hospitals, and variable implementation of PBM activities and monitoring of transfusion practice.

AB - Patient blood management (PBM), as defined by the WHO, is a patient‐focused, evidence‐based and systematic approach to optimize the management of patient and transfusion of blood products for quality and effective patient care. It is designed to improve patient outcomes through the safe and rational use of blood and blood products and by minimizing unnecessary exposure to blood products. Important elements of PBM are optimizing haemoglobin concentrations without blood transfusion, minimizing blood loss and managing anaemia, especially by use of evidence‐based transfusion guidelines and pharmacological agents. Local PBM initiatives differ substantially. In one region of Denmark, the majority of PBM initiatives over the last 10 years have been based on provider education and enforcement of national guidelines. Evaluation of the effect of these initiatives indicated that education alone can be an effective and durable method of reducing unnecessary transfusions. To improve implementation and knowledge of PBM, benchmarking of experiences between hospitals and countries seems rational, and several initiatives regarding PBM are being undertaken in Europe. Patient Blood Management in Europe (PaBloE) is a working group of the European Blood Alliance. Its objectives are to derive good practices in PBM and to develop ways to implement these practices. Within this group, several surveys have been performed relating to blood product consumption, implementation of PBM, and knowledge of PBM principles and practices among clinicians. These surveys have shown variation in transfusion rates between the participating hospitals, and variable implementation of PBM activities and monitoring of transfusion practice.

U2 - 10.1111/voxs.12369

DO - 10.1111/voxs.12369

M3 - Conference article

VL - 12

SP - 435

EP - 440

JO - I S B T Science Series

JF - I S B T Science Series

SN - 1751-2816

IS - 4 (Special Issue)

ER -